Ghent University
Ghent, Oost-Vlaanderen, 9000, Belgium
NCT Number: NCT06204081
The Ceriter Stride One (CSO) is a "smart sole" with pressure sensors. The sole allows data on the displacement of the body's centre of gravity (COG), as well as spatiotemporal parameters, to be obtained via pressure recordings. Logarithms, released on the data captured by the sole, make it possible to recognise propulsion (forward movement of the CG), accompanied by a reduction in step length (festination) or feet remaining standing (freezing of gait). When the system registers incipient propulsion, an audio signal ("stop") is generated via an audio device and app on the mobile phone. The CSO aims to make the pwP stop before balance disturbance can occur, preventing further propulsion and falls.
The aim of the study is to explore the short-term effects of the CSO in terms of reducing (preventing) freezing of gait and fall risk in a pilot group of pwP whose functionality is limited (Hoehn and Yahr 4). Short-term impact on gait (episodes of freezing of gait, mean step length, mean gait speed) will be evaluated and user satisfaction surveyed.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Ghent, Oost-Vlaanderen, 9000, Belgium
There is scientific evidence for making pwP stop at the onset of propulsion (when step length decreases and step frequency increases) in order to get the COG back within the base of support. Similarly, (auditory) cues are recommended to facilitate starting.
These principles are implemented with the CSO : the device makes the pmP stop at onset of propulsion and generates an auditory, rhythmic cue to facilitate starting and walking with larger steps (prevention).
This is an innovative application, not a standard-of-care intervention.
Protocol :
20 persons with Parkinson's disease (H&Y 4) (attending physical therapy at Movita).
The test proceeds in 3 stages : preparation / gait test / subjective evaluation :
Preparation
Clinical gait test :
The soles are placed in the patient's shoes. If the patient uses an assistive device in daily life, the test is performed with an assistive device.
Following procedure is done in a randomized order*:
The first 1.5 minutes gait is performed without a double task, the next 1.5 minutes with a cognitive double task (100 - 3 = ... - 3 = ... -3 = ...).
The first 1.5 minutes gait is performed without a dual task, the next 1.5 minutes with a cognitive dual task (100 - 3 = ... - 3 = ... -3 = ...).
After each condition (with - without auditory cueing) a short break (2 minutes) is taken, during which a Borg scale for fatigue is taken. After the second condition, satisfaction with the effect of the aid is questioned (see below).
The entire gait test is filmed (by a 2nd person). In this way data, including the number of freezing episodes, can be checked.
*Randomization of conditions: per 2 patients. The first patient draws a card indicating whether or not the patient starts with auditory cues while walking. The 2nd patient then starts with the other condition, and so on. Thus we obtain 10 patients starting with the auditory cueing condition and 10 without.
Parameters considered : duration/step, gait asymmetry (pressure of left foot vs. right foot), number of freezing periods, distance walked, number of steps, mean step length.
Satisfaction questions
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Parkinson's disease (or other Parkinsonism)
Exclusion criteria
The sole is worn without using the cueing application
The sole is worn with using the cueing application
Time frame: 2 times 3 minutes
n (number of captured FOG-episodes : the less, the better)
Time frame: 2 times 3 minutes
n (number - more steps relate to a better mobility)
Time frame: 2 times 3 minutes
mean presure data of left foot versus mean pressure data of right foot
Time frame: 2 times 3 minutes
mean step length (cm)
Time frame: after testing (5 min)
comfort and safety of the tool are questioned on a scale of 1 to 10.
University Ghent
Other
Exploration of the Short-term Effects and User Satisfaction of the Ceriter Stride One (CSO) Regarding the Prevention and Treatment of Freezing or Gait in Persons With Parkinson's Disease (pwP).
Acronym: CSO_FOG
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05608915
Basal Ganglia Diseases, Brain Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT06073028
Basal Ganglia Diseases, Brain Diseases
Créteil, France
View Trial DetailsNCT06615115
Basal Ganglia Diseases, Brain Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05510739
Basal Ganglia Diseases, Behavior
Stockholm, Sweden
View Trial Details